Status:
RECRUITING
Membrane Stripping for Cervical Ripening
Lead Sponsor:
Meir Medical Center
Conditions:
Labor, Induced
Cervical Ripening
Eligibility:
FEMALE
18-50 years
Phase:
NA
Brief Summary
The goal of this interventional study is to evaluate the effectiveness of membrane stripping in cervical ripening compared to double balloon catheter induction. The study population consists of women...
Eligibility Criteria
Inclusion
- Patients aged 18 and above
- Patients with a cervical dilation of at least 1 cm
- Full-term pregnancy
- Cephalic presentation
- No contraindication to vaginal delivery
Exclusion
- Patients with rupture of membranes
- Patients who do not require cervical ripening and proceed directly to the delivery room for induction with oxytocin
- Patients for whom the use of a double-balloon catheter is contraindicated
- Twin pregnancies
- Pregnancies with macrosomic fetuses where vaginal delivery is contraindicated
- Vaginal deliveries after a cesarean section
- Patients with maternal or fetal pathologies that do not allow for vaginal delivery due to concerns about fetal or maternal distress
Key Trial Info
Start Date :
August 7 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06591247
Start Date
August 7 2024
End Date
December 31 2026
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Meir Medical Center
Kfar Saba, Central District, Israel, 4428164